Ryman Healthcare shares have resumed trading after it completed the institutional component of its $1 billion capital raise.
The company is looking to raise the cash by way of a $313 million underwritten institutional placement and a $688m underwritten pro-rata entitlement offer, which has both an
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).
